ADAR1 Capital Management »

Spdr Ser Tr 1 3 hgh yield shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Spdr Ser Tr 1 3 hgh yield (BIL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Spdr Ser Tr 1 3 hgh yield

Tip: Access up to 7 years of quarterly data

All positions including Spdr Ser Tr 1 3 hgh yield held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr Ser Tr 1 3 hgh yield by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 32k 91.39

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Spdr Ser Tr 1 3 hgh yield

Bank of America Corporation
UBS Group
Captrust Financial Advisors
Branch Banking & Trust Company
Wells Fargo & Company
Advisor Group Holdings
Capital Wealth Planning
Royal Bank of Canada
Stifel Financial
Beacon Capital Management
AE Wealth Management
CWM
Eagle Capital Management
Oppenheimer Asset Management
Sei Investments

View all funds holding Spdr Ser Tr 1 3 hgh yield